GENB
Generate Biomedicines, Inc.
$17.41
+0.91 (+5.52%)
At close · Jul 2
Market Cap
$2.23B
Shares
128,192,484
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding GENB
25 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| SMALLCAP World Fund Inc | — | 3,650,034 | $45,625,425 | 0.06% | Long | 2026-03-31 | |
| JPMorgan Small Cap Growth Fund | — | 596,468 | $7,455,850 | 0.34% | Long | 2026-03-31 | |
| ARK Genomic Revolution ETF | — | 503,531 | $6,359,597 | 0.51% | Long | 2026-04-30 | |
| JPMorgan Small Cap Value Fund | — | 493,741 | $6,171,763 | 0.54% | Long | 2026-03-31 | |
| JPMorgan U.S. Small Company Fund | — | 391,168 | $4,889,600 | 0.53% | Long | 2026-03-31 | |
| ARK Venture Fund | — | 317,120 | $4,005,226 | 0.46% | Long | 2026-04-30 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 265,641 | $3,320,513 | 0.03% | Long | 2026-03-31 | |
| JPMorgan Small Cap Blend Fund | — | 192,755 | $2,409,438 | 0.17% | Long | 2026-03-31 | |
| JPMorgan Small Cap Value Portfolio | — | 131,034 | $1,637,925 | 0.53% | Long | 2026-03-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 96,876 | $1,210,950 | 0.00% | Long | 2026-03-31 | |
| LVIP JPMorgan Small Cap Core Fund | — | 85,927 | $1,074,088 | 0.53% | Long | 2026-03-31 | |
| VY(R) JPMORGAN SMALL CAP CORE EQUITY PORTFOLIO | — | 58,335 | $729,188 | 0.26% | Long | 2026-03-31 | |
| U.S. Small and Mid Cap Equity Fund | — | 39,715 | $496,438 | 0.51% | Long | 2026-03-31 | |
| TIFF MULTI-ASSET FUND | — | 33,776 | $422,200 | 0.03% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 31,223 | $390,288 | 0.00% | Long | 2026-03-31 | |
| SA Multi-Managed Small Cap Portfolio | — | 18,838 | $235,475 | 0.18% | Long | 2026-03-31 | |
| Health Sciences Trust | — | 18,234 | $227,925 | 0.10% | Long | 2026-03-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 17,700 | $221,250 | 0.01% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Portfolio | — | 16,043 | $200,538 | 0.03% | Long | 2026-03-31 | |
| EQ/T.Rowe Price Health Sciences Portfolio | — | 12,700 | $158,750 | 0.10% | Long | 2026-03-31 | |
| Federated Hermes Managed Volatility Fund II | — | 9,000 | $112,500 | 0.07% | Long | 2026-03-31 | |
| Federated Hermes Muni and Stock Advantage Fund | — | 8,500 | $107,355 | 0.01% | Long | 2026-04-30 | |
| Federated Hermes Prudent Bear Fund | — | 5,000 | $62,500 | 0.06% | Long | 2026-03-31 | |
| VANGUARD BALANCED INDEX FUND | — | 1,747 | $21,838 | 0.00% | Long | 2026-03-31 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 1,473 | $18,413 | 0.00% | Long | 2026-03-31 |
Showing 1–25 of 25 positions
Key facts
CIK
2100782
CUSIP
370920100